rs113947297

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_021930.6(RINT1):​c.840-5G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0321 in 1,613,462 control chromosomes in the GnomAD database, including 1,149 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.026 ( 115 hom., cov: 32)
Exomes 𝑓: 0.033 ( 1034 hom. )

Consequence

RINT1
NM_021930.6 splice_region, intron

Scores

2
Splicing: ADA: 0.0004732
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.588

Publications

6 publications found
Variant links:
Genes affected
RINT1 (HGNC:21876): (RAD50 interactor 1) This gene encodes a protein first identified for its ability to interact with the RAD50 double strand break repair protein, with the resulting interaction implicated in the regulation of cell cycle progression and telomere length. The encoded protein may also play a role in trafficking of cellular cargo from the endosome to the trans-Golgi network. Mutations in this gene may be associated with breast cancer in human patients. [provided by RefSeq, Oct 2016]
RINT1 Gene-Disease associations (from GenCC):
  • infantile liver failure syndrome 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • infantile liver failure syndrome 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 7-105548549-G-A is Benign according to our data. Variant chr7-105548549-G-A is described in ClinVar as Benign. ClinVar VariationId is 416378.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0264 (4011/152166) while in subpopulation NFE AF = 0.0381 (2594/67998). AF 95% confidence interval is 0.0369. There are 115 homozygotes in GnomAd4. There are 1992 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 115 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RINT1NM_021930.6 linkc.840-5G>A splice_region_variant, intron_variant Intron 6 of 14 ENST00000257700.7 NP_068749.3 Q6NUQ1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RINT1ENST00000257700.7 linkc.840-5G>A splice_region_variant, intron_variant Intron 6 of 14 1 NM_021930.6 ENSP00000257700.2 Q6NUQ1
RINT1ENST00000497979.5 linkn.*445-5G>A splice_region_variant, intron_variant Intron 6 of 14 5 ENSP00000420582.1 F8WDC5

Frequencies

GnomAD3 genomes
AF:
0.0264
AC:
4011
AN:
152048
Hom.:
115
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00654
Gnomad AMI
AF:
0.0758
Gnomad AMR
AF:
0.00944
Gnomad ASJ
AF:
0.00894
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.0805
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0381
Gnomad OTH
AF:
0.0168
GnomAD2 exomes
AF:
0.0264
AC:
6645
AN:
251414
AF XY:
0.0261
show subpopulations
Gnomad AFR exome
AF:
0.00486
Gnomad AMR exome
AF:
0.00610
Gnomad ASJ exome
AF:
0.00754
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0804
Gnomad NFE exome
AF:
0.0377
Gnomad OTH exome
AF:
0.0274
GnomAD4 exome
AF:
0.0327
AC:
47835
AN:
1461296
Hom.:
1034
Cov.:
31
AF XY:
0.0319
AC XY:
23203
AN XY:
726964
show subpopulations
African (AFR)
AF:
0.00454
AC:
152
AN:
33470
American (AMR)
AF:
0.00695
AC:
311
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00796
AC:
208
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39688
South Asian (SAS)
AF:
0.00310
AC:
267
AN:
86256
European-Finnish (FIN)
AF:
0.0847
AC:
4524
AN:
53404
Middle Eastern (MID)
AF:
0.0146
AC:
84
AN:
5766
European-Non Finnish (NFE)
AF:
0.0364
AC:
40500
AN:
1111480
Other (OTH)
AF:
0.0296
AC:
1788
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
2051
4102
6154
8205
10256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1440
2880
4320
5760
7200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0264
AC:
4011
AN:
152166
Hom.:
115
Cov.:
32
AF XY:
0.0268
AC XY:
1992
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.00653
AC:
271
AN:
41528
American (AMR)
AF:
0.00943
AC:
144
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00894
AC:
31
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00270
AC:
13
AN:
4820
European-Finnish (FIN)
AF:
0.0805
AC:
852
AN:
10584
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0381
AC:
2594
AN:
67998
Other (OTH)
AF:
0.0166
AC:
35
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
200
400
600
800
1000
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0337
Hom.:
197
Bravo
AF:
0.0206
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0291
EpiControl
AF:
0.0289

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 30, 2020
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

RINT1-related disorder Benign:1
Oct 28, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
11
DANN
Benign
0.70
PhyloP100
0.59
Mutation Taster
=84/16
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00047
dbscSNV1_RF
Benign
0.062
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113947297; hg19: chr7-105188996; API